FFL
ADMA icon

Future Fund LLC’s ADMA Biologics ADMA Stock Holding History

Future Fund LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
248,524
+64,508
+35% +$588K 0.6% 70
2026
Q1 		$1.66M Buy
184,016
+86,584
+89% +$1.37M 0.58% 78
2025
Q4 		$1.78M Buy
97,432
+33,312
+52% +$561K 0.56% 63
2025
Q3 		$940K Buy
64,120
+23,945
+60% +$410K 0.33% 126
2025
Q2 		$732K Buy
+40,175
New +$819K 0.33% 127

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Future Fund LLC's ADMA Position: Q2 2026 in Review

Future Fund LLC increased its ADMA Biologics (ADMA) stake by 35% in Q2 2026, buying an estimated $588K and bringing the position to 248,524 shares worth $2.08M. The position accounts for 0.6% of the portfolio, ranked #70.

Future Fund LLC first reported a position in ADMA in Q2 2025 and has held it in 5 quarters since. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Future Fund LLC held 248,524 shares of ADMA Biologics worth $2.08M as of Q2 2026.
  • Future Fund LLC bought 64,508 ADMA Biologics shares in Q2 2026, an estimated $588K.
  • ADMA Biologics made up 0.6% of Future Fund LLC's portfolio in Q2 2026, its #70 holding.
  • Future Fund LLC first reported a position in ADMA Biologics in Q2 2025 and has held it in 5 quarters since.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Future Fund LLC's 13F filing for Q2 2026, filed 12 Aug 2026.